Chronic aminophylline administration: Effect on diaphragm contractility and fatigue resistance in vitro

J. H. Kuei, Gary C Sieck

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The effects of acute and chronic administrations of aminophylline (AM) on diaphragm contractility and fatigue resistance were examined in 42 rats. In acute experiments (n = 22), the animals received an intravenous bolus of either AM (14 mg/kg; n = 11) or saline (n = 11). Serum AM level was determined 30 min after the bolus (17.8 ± 0.8 mg/L, SD). In chronic experiments (n = 20), either AM (n = 10) or saline (n = 10) was infused subcutaneously via an osmotic minipump at a constant pumping rate of 2.5 μl/h. Serum AM level was measured after 2 wk of pump infusion (12.3 ± 2.0 mg/L, SD). For each animal in both acute and chronic experiments, a muscle strip from the right midcostal diaphragm was placed in an in vitro chamber containing Krebs solution and 12 μM/L curare. For the AM-treated group, AM was added to the tissue bath in a concentration similar to that in the serum. No AM was added to the bath for the control group. Forces were measured isometrically during direct muscle stimulation at different frequencies and standardized to muscle weight. Muscle fatigue was induced by repetitive stimulation at 40 pps, delivered in 330-ms trains, with one train presented each second. With either acute or chronic AM administration, a significant increase in diaphragm contractility was observed (p < 0.01). In contrast, AM did not affect the rate of force decline during fatigue run. However, the time required to produce 50% reduction from the initial tension was longer in both AM-treated groups. We conclude that AM improves diaphragm contractility, but not fatigue resistance, and the improvement in diaphragm contractility persists after 2 wk of AM treatment.

Original languageEnglish (US)
Pages (from-to)121-125
Number of pages5
JournalAmerican Review of Respiratory Disease
Volume144
Issue number1
StatePublished - 1991
Externally publishedYes

Fingerprint

Aminophylline
Diaphragm
Fatigue
Baths
Muscles
In Vitro Techniques
Serum
Curare
Infusion Pumps
Muscle Fatigue

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Chronic aminophylline administration : Effect on diaphragm contractility and fatigue resistance in vitro. / Kuei, J. H.; Sieck, Gary C.

In: American Review of Respiratory Disease, Vol. 144, No. 1, 1991, p. 121-125.

Research output: Contribution to journalArticle

@article{8a592a71cb1d4f8d9a8de203824baf92,
title = "Chronic aminophylline administration: Effect on diaphragm contractility and fatigue resistance in vitro",
abstract = "The effects of acute and chronic administrations of aminophylline (AM) on diaphragm contractility and fatigue resistance were examined in 42 rats. In acute experiments (n = 22), the animals received an intravenous bolus of either AM (14 mg/kg; n = 11) or saline (n = 11). Serum AM level was determined 30 min after the bolus (17.8 ± 0.8 mg/L, SD). In chronic experiments (n = 20), either AM (n = 10) or saline (n = 10) was infused subcutaneously via an osmotic minipump at a constant pumping rate of 2.5 μl/h. Serum AM level was measured after 2 wk of pump infusion (12.3 ± 2.0 mg/L, SD). For each animal in both acute and chronic experiments, a muscle strip from the right midcostal diaphragm was placed in an in vitro chamber containing Krebs solution and 12 μM/L curare. For the AM-treated group, AM was added to the tissue bath in a concentration similar to that in the serum. No AM was added to the bath for the control group. Forces were measured isometrically during direct muscle stimulation at different frequencies and standardized to muscle weight. Muscle fatigue was induced by repetitive stimulation at 40 pps, delivered in 330-ms trains, with one train presented each second. With either acute or chronic AM administration, a significant increase in diaphragm contractility was observed (p < 0.01). In contrast, AM did not affect the rate of force decline during fatigue run. However, the time required to produce 50{\%} reduction from the initial tension was longer in both AM-treated groups. We conclude that AM improves diaphragm contractility, but not fatigue resistance, and the improvement in diaphragm contractility persists after 2 wk of AM treatment.",
author = "Kuei, {J. H.} and Sieck, {Gary C}",
year = "1991",
language = "English (US)",
volume = "144",
pages = "121--125",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "1",

}

TY - JOUR

T1 - Chronic aminophylline administration

T2 - Effect on diaphragm contractility and fatigue resistance in vitro

AU - Kuei, J. H.

AU - Sieck, Gary C

PY - 1991

Y1 - 1991

N2 - The effects of acute and chronic administrations of aminophylline (AM) on diaphragm contractility and fatigue resistance were examined in 42 rats. In acute experiments (n = 22), the animals received an intravenous bolus of either AM (14 mg/kg; n = 11) or saline (n = 11). Serum AM level was determined 30 min after the bolus (17.8 ± 0.8 mg/L, SD). In chronic experiments (n = 20), either AM (n = 10) or saline (n = 10) was infused subcutaneously via an osmotic minipump at a constant pumping rate of 2.5 μl/h. Serum AM level was measured after 2 wk of pump infusion (12.3 ± 2.0 mg/L, SD). For each animal in both acute and chronic experiments, a muscle strip from the right midcostal diaphragm was placed in an in vitro chamber containing Krebs solution and 12 μM/L curare. For the AM-treated group, AM was added to the tissue bath in a concentration similar to that in the serum. No AM was added to the bath for the control group. Forces were measured isometrically during direct muscle stimulation at different frequencies and standardized to muscle weight. Muscle fatigue was induced by repetitive stimulation at 40 pps, delivered in 330-ms trains, with one train presented each second. With either acute or chronic AM administration, a significant increase in diaphragm contractility was observed (p < 0.01). In contrast, AM did not affect the rate of force decline during fatigue run. However, the time required to produce 50% reduction from the initial tension was longer in both AM-treated groups. We conclude that AM improves diaphragm contractility, but not fatigue resistance, and the improvement in diaphragm contractility persists after 2 wk of AM treatment.

AB - The effects of acute and chronic administrations of aminophylline (AM) on diaphragm contractility and fatigue resistance were examined in 42 rats. In acute experiments (n = 22), the animals received an intravenous bolus of either AM (14 mg/kg; n = 11) or saline (n = 11). Serum AM level was determined 30 min after the bolus (17.8 ± 0.8 mg/L, SD). In chronic experiments (n = 20), either AM (n = 10) or saline (n = 10) was infused subcutaneously via an osmotic minipump at a constant pumping rate of 2.5 μl/h. Serum AM level was measured after 2 wk of pump infusion (12.3 ± 2.0 mg/L, SD). For each animal in both acute and chronic experiments, a muscle strip from the right midcostal diaphragm was placed in an in vitro chamber containing Krebs solution and 12 μM/L curare. For the AM-treated group, AM was added to the tissue bath in a concentration similar to that in the serum. No AM was added to the bath for the control group. Forces were measured isometrically during direct muscle stimulation at different frequencies and standardized to muscle weight. Muscle fatigue was induced by repetitive stimulation at 40 pps, delivered in 330-ms trains, with one train presented each second. With either acute or chronic AM administration, a significant increase in diaphragm contractility was observed (p < 0.01). In contrast, AM did not affect the rate of force decline during fatigue run. However, the time required to produce 50% reduction from the initial tension was longer in both AM-treated groups. We conclude that AM improves diaphragm contractility, but not fatigue resistance, and the improvement in diaphragm contractility persists after 2 wk of AM treatment.

UR - http://www.scopus.com/inward/record.url?scp=0025896103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025896103&partnerID=8YFLogxK

M3 - Article

C2 - 2064117

AN - SCOPUS:0025896103

VL - 144

SP - 121

EP - 125

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 1

ER -